Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Ralph De Fronzo

Ralph De Fronzo
Department of Medicine - Diabetes
Texas Diabetes Institute - University Health system
University of Texas Health Science Center San Antonio
San Antonio (TX), Texas, United States

Ralph Antony De Fronzo, MD is a Professor of Medicine, the Chief of the Diabetes Division at the University of Texas Health Science Center and the Deputy Director of the Texas Diabetes Institute, San Antonio, Texas. Dr. DeFronzo served as Member of Scientific Advisory Board at Diamedica Inc. since June 2014. Dr. DeFronzo has served as an Advisory Board member for several pharmaceutical companies and has delivered numerous keynote speeches at major national and international conferences on diabetes and its complications. His major interests focus on the pathogenesis and treatment of type 2 diabetes mellitus and the central role of insulin resistance in the metabolic-cardiovascular cluster of disorders known collectively as the Insulin Resistance Syndrome. Using the euglycemic insulin clamp technique in combination with radioisotope turnover methodology, limb catheterization, indirect calorimetry and muscle biopsy, he has helped to define the biochemical and molecular disturbances responsible for insulin resistance in type 2 diabetes mellitus. With more than 650 articles published in peer-reviewed medical journals, Dr. DeFronzo is a distinguished diabetes researcher, clinician and teacher and is a recipient of several prestigious national and international awards. In 2008, Dr. DeFronzo received the Banting Award from the American Diabetes Association (ADA) and the Claude Bernard Award from the European Association for the Study of Diabetes (EASD). In 2008, Dr. DeFronzo also received the Italian Diabetes Mentor Prize and the Philip Bondy Lectureship at Yale University. He also is the recipient of the ADA's Albert Renold Award (2002) for lifetime commitment to the training of young diabetes investigators. For his work in this area, Dr. DeFronzo received the prestigious Lilly Award (1987) from the ADA, the Banting Lectureship (1988) from the Canadian Diabetes Association and the Novartis Award (2003) for outstanding clinical investigation worldwide. Dr. DeFronzo is a graduate of Yale University (BS) and Harvard Medical School (MD) and completed his training in Internal Medicine at the Johns Hopkins Hospital. He completed fellowships in Endocrinology at the National Institutes of Health and Baltimore City Hospitals and in Nephrology at the Hospital of the University of Pennsylvania.